Waystar initiated with a Buy at Truist

Truist initiated coverage of Waystar (WAY) with a Buy rating and $45 price target The company is positioned to benefit from the evolution that the healthcare payments workflow is currently undergoing where providers are increasingly looking for automated software solutions to reduce administrative burden and improve efficiency, the analyst tells investors in a research note. The firm believes Waystar has approached its 2025 guidance conservatively, and would not be surprised to see another year of “beat and raise” quarters.